We are testing JAMES at our company (Signature Domains, Inc.
[http://www.signaturedomains.com/]) for two purposes:
1.) Email forwarding. We have already written a simple mailet which looks
in our MySql database for the incoming email address and then switches the
address to a different address.
2.) As a general SMTP server. We are using JAMES for general SMTP
communication. We are also going to implement a mailet which archives all
incoming messages to our database.
All in all, the concept of mailets is so powerful - I can think of hundreds
of things I would like to use it for.
One more thing: I would REALLY love to see JAMES work with IMAP. Any
thoughts on when this may occur?
Sincerely,
Anthony Eden
[EMAIL PROTECTED]
--
Signature Domains, Inc.
4021 Laguna St.
Miami, FL 33146
Phone: 305 446 6811
Fax: 305 446 3456
http://www.signaturedomains.com/
----------
>From: Serge Knystautas <[EMAIL PROTECTED]>
>To: [EMAIL PROTECTED]
>Subject: Testing
>Date: Thu, Jul 6, 2000, 11:10 AM
>
> Is anybody else out there actively testing James? I've just invited
> anyone within our company to start using my installation of JAMES for
> their outgoing mail server and plan by the end of the month to replace
> our external mail server with JAMES. We won't be using it for POP3 (as
> we're an IMAP4 shop and hope JAMES can one day support this), but we'll
> be writing some great mailets for projects and internal processes.
>
> If anybody has any bug reports, please send them to the list (or me if
> you want) as we try to put out a new release in the next week or two.
>
> Serge Knystautas
> Loki Technologies
> http://www.lokitech.com/
>
>
> ------------------------------------------------------------
> To subscribe: [EMAIL PROTECTED]
> To unsubscribe: [EMAIL PROTECTED]
> Archives and Other: <http://java.apache.org/>
> Problems?: [EMAIL PROTECTED]
>
------------------------------------------------------------
To subscribe: [EMAIL PROTECTED]
To unsubscribe: [EMAIL PROTECTED]
Archives and Other: <http://java.apache.org/>
Problems?: [EMAIL PROTECTED]